Patent Landscape Report on Cannabis & Cannabinoids 

14,000+ Patent Families | 1868–Present !🌿 🧪📘

Summary of the Study: Cannabis & Cannabinoids 🌿🧪📘

Cannabis, a genus of flowering plants including Cannabis sativa, indica, and ruderalis, has been used for centuries for medicinal and recreational purposes. Its active compounds—cannabinoids—include widely studied substances such as THC, CBD, and CBN, alongside over 100 other known cannabinoids. 💊🧠🌱

The first cannabis-related patent was filed in the U.S. in 1868 by George Mohler (US82541A), claiming a medicinal composition using Cannabis Indica to treat bronchitis and asthma. Another notable early filing is US302116A (1884), also focused on cannabis-based therapeutic properties. 📜⚖️

Between 1884 and 1990, patent activity remained low—fewer than 20 filings per year. Post-1990, however, filings surged significantly. A recent search shows nearly 14,000 patent families containing the terms Cannabi or Marijuana in the title, abstract, or claims. 🔍📄📈

To support companies in healthcare, food, beverage, and wellness, Mark IP has developed a comprehensive Patent Landscape Report (PLR) covering 152 years of cannabis-related patent data (1868–Present). 📘📅

Our analysts manually reviewed 14,000+ patent families, classifying 10,000+ relevant families into structured first- and second-level taxonomy. The report also includes:

1. All claimed uses of cannabis and cannabinoids

2. Types of compounds, including derivatives, salts, and metabolites 🧪📂
   
   

With the global cannabis market projected to reach $97 billion by 2026, this PLR offers critical insights for organizations developing therapeutic, recreational, or commercial cannabis-based products. 💼🚀🌿